Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 5, 2000, Pages 1773-1777

  Papi, A ^a   Romagnoli, M ^a   Baraldo, S ^a   Braccioni, F ^a   Guzzinati, I ^a   Saetta, M ^a   Ciaccia, A ^a   Fabbri, L M ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; SALBUTAMOL;

ARTICLE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; EXPIRED AIR; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATORY CELL; PRIORITY JOURNAL; RESPIRATORY AIRFLOW; SPUTUM; TREATMENT OUTCOME;

EID: 0033711405     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.5.9910112     Document Type: Article

References (35)

1. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease: American Thoracic Society
2. Optimal assessment and management of chronic obstructive pulmonary disease (COPD): The European Respiratory Society Task Force
3. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease: Dutch Chronic Non-Specific Lung Disease Study Group
4. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD
5. Corticosteroid reversibility in COPD is related to features of asthma
6. Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema
7. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease
8. Can exhaled NO be used as a marker of airway inflammation?
9. Exhaled nitric oxide: A new lung function test
10. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma
11. Exhaled nitric oxide in chronic obstructive pulmonary disease
12. Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease
13. Measurement of exhaled nitric oxide by three different techniques
14. Nitric oxide measured with single-breath and tidal-breathing methods in asthma and COPD
15. Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease
16. Increased production of endogenous nitric oxide in patients with bronchial asthma and chronic obstructive pulmonary disease
17. Spirometry: Quality control and reproducibility criteria
18. Standardization of spirometry, 1994 update
19. Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo
20. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society
21. Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract
22. Exhaled and nasal nitric oxide measurements: Recommendations
23. Nitric oxide from the human respiratory tract efficiently quantified by standardized single breath measurements
24. Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage
25. Bronchodilator response in chronic obstructive pulmonary disease
26. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: A meta-analysis
27. Pathology
28. Pathophysiology of chronic obstructive pulmonary disease
29. Endogenous nitric oxide in patients with stable COPD: Correlates with severity of disease
30. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: Effect of inhaled glucocorticoid
31. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma
32. Airway pathology of COPD compared with asthma
33. The cellular composition of induced sputum in chronic obstructive pulmonary disease
34. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis